Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters











Publication year range
1.
bioRxiv ; 2024 Feb 09.
Article in English | MEDLINE | ID: mdl-38370834

ABSTRACT

The DAF-2/insulin/insulin-like growth factor signaling (IIS) pathway plays an evolutionarily conserved role in regulating reproductive development, lifespan, and stress resistance. In C. elegans , DAF-2/IIS signaling is modulated by an extensive array of insulin-like peptides (ILPs) with diverse spatial and temporal expression patterns. However, the release dynamics and specific functions of these ILPs in adapting to different environmental conditions remain poorly understood. Here, we show that the ILP, INS-3, plays a crucial role in modulating the response to different types of stressors in C. elegans . ins-3 mutants display increased resistance to both heat and oxidative stress; however, under favorable conditions, this advantage is countered by slower reproductive development. ins-3 expression in both neurons and the intestine is downregulated in response to environmental stressors. Conversely, the neurohormone tyramine, which is released during the acute flight response, triggers an upregulation in ins-3 expression. Moreover, we found that tyramine negatively impacts environmental stress resistance by stimulating the release of INS-3 from the intestine. The subsequent release of INS-3 systemically activates the DAF-2 pathway, resulting in the inhibition of cytoprotective mechanisms mediated by DAF-16/FOXO and HSF-1. These studies offer mechanistic insights into the brain-gut communication pathway that weighs adaptive strategies to respond to acute and long-term stress scenarios.

2.
Elife ; 122023 10 27.
Article in English | MEDLINE | ID: mdl-37889153

ABSTRACT

A molecular pathway involving compounds found in processed foods and biogenic amines increases food intake and aging in the roundworm C. elegans.


Subject(s)
Caenorhabditis elegans , Nematoda , Animals , Caenorhabditis elegans/metabolism , Biogenic Amines/metabolism , Hyperphagia
3.
Front Pharmacol ; 13: 908696, 2022.
Article in English | MEDLINE | ID: mdl-35685626

ABSTRACT

Due to the increase in life expectancy worldwide, age-related disorders such as neurodegenerative diseases (NDs) have become more prevalent. Conventional treatments comprise drugs that only attenuate some of the symptoms, but fail to arrest or delay neuronal proteotoxicity that characterizes these diseases. Due to their diverse biological activities, imidazole rings are intensively explored as powerful scaffolds for the development of new bioactive molecules. By using C. elegans, our work aims to explore novel biological roles for these compounds. To this end, we have tested the in vivo anti-proteotoxic effects of imidazolium salts. Since NDs have been largely linked to impaired antioxidant defense mechanisms, we focused on 1-Mesityl-3-(3-sulfonatopropyl) imidazolium (MSI), one of the imidazolium salts that we identified as capable of improving iron-induced oxidative stress resistance in wild-type animals. By combining mutant and gene expression analysis we have determined that this protective effect depends on the activation of the Heat Shock Transcription Factor (HSF-1), whereas it is independent of other canonical cytoprotective molecules such as abnormal Dauer Formation-16 (DAF-16/FOXO) and Skinhead-1 (SKN-1/Nrf2). To delve deeper into the biological roles of MSI, we analyzed the impact of this compound on previously established C. elegans models of protein aggregation. We found that MSI ameliorates ß-amyloid-induced paralysis in worms expressing the pathological protein involved in Alzheimer's Disease. Moreover, this compound also delays age-related locomotion decline in other proteotoxic C. elegans models, suggesting a broad protective effect. Taken together, our results point to MSI as a promising anti-proteotoxic compound and provide proof of concept of the potential of imidazole derivatives in the development of novel therapies to retard age-related proteotoxic diseases.

4.
Pharmacol Res Perspect ; 9(2): e00721, 2021 04.
Article in English | MEDLINE | ID: mdl-33641258

ABSTRACT

Therapeutic drug development is a long, expensive, and complex process that usually takes 12-15 years. In the early phases of drug discovery, in particular, there is a growing need for animal models that ensure the reduction in both cost and time. Caenorhabditis elegans has been traditionally used to address fundamental aspects of key biological processes, such as apoptosis, aging, and gene expression regulation. During the last decade, with the advent of large-scale platforms for screenings, this invertebrate has also emerged as an essential tool in the pharmaceutical research industry to identify novel drugs and drug targets. In this review, we discuss the reasons why C. elegans has been positioned as an outstanding cost-effective option for drug discovery, highlighting both the advantages and drawbacks of this model. Particular attention is paid to the suitability of this nematode in large-scale genetic and pharmacological screenings. High-throughput screenings in C. elegans have indeed contributed to the breakthrough of a wide variety of candidate compounds involved in extensive fields including neurodegeneration, pathogen infections and metabolic disorders. The versatility of this nematode, which enables its instrumentation as a model of human diseases, is another attribute also herein underscored. As illustrative examples, we discuss the utility of C. elegans models of both human neurodegenerative diseases and parasitic nematodes in the drug discovery industry. Summing up, this review aims to demonstrate the impact of C. elegans models on the drug discovery pipeline.


Subject(s)
Caenorhabditis elegans/physiology , Drug Discovery/methods , Drug Evaluation, Preclinical/methods , Animals , Drug Evaluation, Preclinical/economics , High-Throughput Screening Assays/economics , High-Throughput Screening Assays/methods , Humans , Models, Animal , Species Specificity
6.
Nature ; 573(7772): 135-138, 2019 09.
Article in English | MEDLINE | ID: mdl-31462774

ABSTRACT

An animal's stress response requires different adaptive strategies depending on the nature and duration of the stressor. Whereas acute stressors, such as predation, induce a rapid and energy-demanding fight-or-flight response, long-term environmental stressors induce the gradual and long-lasting activation of highly conserved cytoprotective processes1-3. In animals across the evolutionary spectrum, continued activation of the fight-or-flight response weakens the animal's resistance to environmental challenges4,5. However, the molecular and cellular mechanisms that regulate the trade-off between the flight response and long-term stressors are poorly understood. Here we show that repeated induction of the flight response in Caenorhabditis elegans shortens lifespan and inhibits conserved cytoprotective mechanisms. The flight response activates neurons that release tyramine, an invertebrate analogue of adrenaline and noradrenaline. Tyramine stimulates the insulin-IGF-1 signalling (IIS) pathway and precludes the induction of stress response genes by activating an adrenergic-like receptor in the intestine. By contrast, long-term environmental stressors, such as heat or oxidative stress, reduce tyramine release and thereby allow the induction of cytoprotective genes. These findings demonstrate that a neural stress hormone supplies a state-dependent neural switch between acute flight and long-term environmental stress responses and provides mechanistic insights into how the flight response impairs cellular defence systems and accelerates ageing.


Subject(s)
Caenorhabditis elegans/cytology , Caenorhabditis elegans/physiology , Cytoprotection , Insulin/metabolism , Tyramine/metabolism , Active Transport, Cell Nucleus , Animals , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/metabolism , Cell Nucleus/metabolism , Forkhead Transcription Factors/metabolism , Insulin-Like Growth Factor I/metabolism , Intestinal Mucosa/metabolism , Longevity , Neurons/metabolism , Receptors, Adrenergic/metabolism , Receptors, Catecholamine/metabolism , Signal Transduction , Stress, Psychological
7.
Elife ; 82019 08 05.
Article in English | MEDLINE | ID: mdl-31364988

ABSTRACT

Mutations in pre-synaptic voltage-gated calcium channels can lead to familial hemiplegic migraine type 1 (FHM1). While mammalian studies indicate that the migraine brain is hyperexcitable due to enhanced excitation or reduced inhibition, the molecular and cellular mechanisms underlying this excitatory/inhibitory (E/I) imbalance are poorly understood. We identified a gain-of-function (gf) mutation in the Caenorhabditis elegans CaV2 channel α1 subunit, UNC-2, which leads to increased calcium currents. unc-2(zf35gf) mutants exhibit hyperactivity and seizure-like motor behaviors. Expression of the unc-2 gene with FHM1 substitutions R192Q and S218L leads to hyperactivity similar to that of unc-2(zf35gf) mutants. unc-2(zf35gf) mutants display increased cholinergic and decreased GABAergic transmission. Moreover, increased cholinergic transmission in unc-2(zf35gf) mutants leads to an increase of cholinergic synapses and a TAX-6/calcineurin-dependent reduction of GABA synapses. Our studies reveal mechanisms through which CaV2 gain-of-function mutations disrupt excitation-inhibition balance in the nervous system.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/physiology , Gain of Function Mutation , Membrane Proteins/metabolism , Mutant Proteins/metabolism , Synaptic Transmission , Animals , Caenorhabditis elegans Proteins/genetics , Calcium/metabolism , Membrane Proteins/genetics , Mutant Proteins/genetics
8.
Nat Commun ; 10(1): 3186, 2019 07 18.
Article in English | MEDLINE | ID: mdl-31320626

ABSTRACT

Biogenic amine neurotransmitters play a central role in metazoan biology, and both their chemical structures and cognate receptors are evolutionarily conserved. Their primary roles are in cell-to-cell signaling, as biogenic amines are not normally recruited for communication between separate individuals. Here, we show that in the nematode C. elegans, a neurotransmitter-sensing G protein-coupled receptor, TYRA-2, is required for avoidance responses to osas#9, an ascaroside pheromone that incorporates the neurotransmitter, octopamine. Neuronal ablation, cell-specific genetic rescue, and calcium imaging show that tyra-2 expression in the nociceptive neuron, ASH, is necessary and sufficient to induce osas#9 avoidance. Ectopic expression in the AWA neuron, which is generally associated with attractive responses, reverses the response to osas#9, resulting in attraction instead of avoidance behavior, confirming that TYRA-2 partakes in the sensing of osas#9. The TYRA-2/osas#9 signaling system represents an inter-organismal communication channel that evolved via co-option of a neurotransmitter and its cognate receptor.


Subject(s)
Avoidance Learning/physiology , Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/metabolism , Cell Communication/physiology , Octopamine/metabolism , Receptors, Biogenic Amine/metabolism , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/genetics , Nociceptors/metabolism , Receptors, Biogenic Amine/genetics , Signal Transduction
9.
PLoS Negl Trop Dis ; 12(12): e0007021, 2018 12.
Article in English | MEDLINE | ID: mdl-30557347

ABSTRACT

Nematode parasites cause substantial morbidity to billions of people and considerable losses in livestock and food crops. The repertoire of effective anthelmintic compounds for treating these parasitoses is very limited, as drug development has been delayed for decades. Moreover, resistance has become a global concern in livestock parasites and is an emerging issue for human helminthiasis. Therefore, anthelmintics with novel mechanisms of action are urgently needed. Taking advantage of Caenorhabditis elegans as an established model system, we here screened the nematicidal potential of novel imidazolium and imidazole derivatives. One of these derivatives, diisopropylphenyl-imidazole (DII), is lethal to C. elegans at both mature and immature stages. This lethal effect appears to be specific because DII concentrations which prove to be toxic to C. elegans do not induce significant lethality on bacteria, Drosophila melanogaster, and HEK-293 cells. Our analysis of DII action on C. elegans mutant strains determined that, in the adult stage, null mutants of unc-29 are resistant to the drug. Muscle expression of this gene completely restores DII sensitivity. UNC-29 has been largely reported as an essential constituent of the levamisole-sensitive muscle nicotinic receptor (L-AChR). Nevertheless, null mutants in unc-63 and lev-8 (essential and non-essential subunits of L-AChRs, respectively) are as sensitive to DII as the wild-type strain. Therefore, our results suggest that DII effects on adult nematodes rely on a previously unidentified UNC-29-containing muscle AChR, different from the classical L-AChR. Interestingly, DII targets appear to be different between larvae and adults, as unc-29 null mutant larvae are sensitive to the drug. The existence of more than one target could delay resistance development. Its lethality on C. elegans, its harmlessness in non-nematode species and its novel and dual mechanism of action make DII a promising candidate compound for anthelmintic therapy.


Subject(s)
Anthelmintics/pharmacology , Caenorhabditis elegans/drug effects , Imidazoles/pharmacology , Animals , Anthelmintics/chemical synthesis , Anthelmintics/chemistry , Caenorhabditis elegans/genetics , Caenorhabditis elegans/growth & development , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Cell Survival/drug effects , Drosophila melanogaster/drug effects , Drosophila melanogaster/genetics , Female , HEK293 Cells , Humans , Imidazoles/chemical synthesis , Imidazoles/chemistry , Male , Molecular Structure , Receptors, Nicotinic/genetics , Receptors, Nicotinic/metabolism
10.
Curr Biol ; 26(9): R362-4, 2016 05 09.
Article in English | MEDLINE | ID: mdl-27166694

ABSTRACT

A recent study has found that pathogen exposure early in the life of the nematode Caenorhabditis elegans leads to a long-lasting aversion that requires distinct sets of neurons for the formation and retrieval of the imprinted memory.


Subject(s)
Bacteria/classification , Caenorhabditis elegans/microbiology , Caenorhabditis elegans/physiology , Imprinting, Psychological/physiology , Animals , Host-Pathogen Interactions , Larva/microbiology , Larva/physiology , Neurons/physiology
11.
PLoS Biol ; 13(9): e1002238, 2015.
Article in English | MEDLINE | ID: mdl-26348462

ABSTRACT

Behavioral output of neural networks depends on a delicate balance between excitatory and inhibitory synaptic connections. However, it is not known whether network formation and stability is constrained by the sign of synaptic connections between neurons within the network. Here we show that switching the sign of a synapse within a neural circuit can reverse the behavioral output. The inhibitory tyramine-gated chloride channel, LGC-55, induces head relaxation and inhibits forward locomotion during the Caenorhabditis elegans escape response. We switched the ion selectivity of an inhibitory LGC-55 anion channel to an excitatory LGC-55 cation channel. The engineered cation channel is properly trafficked in the native neural circuit and results in behavioral responses that are opposite to those produced by activation of the LGC-55 anion channel. Our findings indicate that switches in ion selectivity of ligand-gated ion channels (LGICs) do not affect network connectivity or stability and may provide an evolutionary and a synthetic mechanism to change behavior.


Subject(s)
Behavior, Animal/physiology , Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/physiology , Receptors, Biogenic Amine/metabolism , Synaptic Potentials , Tyramine/metabolism , Amino Acid Sequence , Animals , Animals, Genetically Modified , Caenorhabditis elegans Proteins/genetics , Genetic Engineering , Molecular Sequence Data , Receptors, Biogenic Amine/genetics
12.
Mol Pharmacol ; 82(3): 550-60, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22734069

ABSTRACT

Caenorhabditis elegans muscle contains seven different nicotinic receptor (AChR) subunits, five of which have been shown to be components of adult levamisole-sensitive AChRs (L-AChRs). To elucidate the reason for such subunit diversity, we explore their functional roles in larva 1 (L1) muscle cells. Single-channel and macroscopic current recordings reveal that the α-type LEV-8 subunit is a component of native L1 L-AChRs but behaves as a nonessential subunit. It plays a key role in maintaining a low rate and extent of desensitization of L-AChRs. In the absence of the α-type ACR-8 subunit, L-AChR channel properties are not modified, thus indicating that ACR-8 is not a component of L1 L-AChRs. Together with our previous findings, this study reveals that L1 muscle cells express a main L-AChR type composed of five different subunits: UNC-38, UNC-63, UNC-29, LEV-1, and LEV-8. Analysis of a double lev-8; acr-8-null mutant, which shows an uncoordinated and levamisole-resistant phenotype, reveals that ACR-8 can replace LEV-8 in its absence, thus attributing a functional role to this subunit. Docking into homology modeled L-AChRs proposes that ACh forms the typical cation-π interaction, suggests why levamisole is less efficacious than ACh, and shows that ACR-8 can form activatable binding-sites, thus opening doors for elucidating subunit arrangement and anthelmintic selectivity.


Subject(s)
Caenorhabditis elegans/metabolism , Levamisole/pharmacology , Muscle Cells/drug effects , Muscle Cells/metabolism , Receptors, Nicotinic/metabolism , Acetylcholine/pharmacology , Animals , Antirheumatic Agents/pharmacology , Binding Sites/drug effects , Binding Sites/genetics , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Larva/drug effects , Larva/genetics , Larva/metabolism , Muscles/drug effects , Muscles/metabolism , Mutation/genetics , Phenotype , Protein Subunits/genetics , Protein Subunits/metabolism , Receptors, Nicotinic/genetics
13.
J Biol Chem ; 286(4): 2550-8, 2011 Jan 28.
Article in English | MEDLINE | ID: mdl-20966081

ABSTRACT

The nematode Caenorhabditis elegans is an established model organism for studying neurobiology. UNC-63 is a C. elegans nicotinic acetylcholine receptor (nAChR) α-subunit. It is an essential component of the levamisole-sensitive muscle nAChR (L-nAChR) and therefore plays an important role in cholinergic transmission at the nematode neuromuscular junction. Here, we show that worms with the unc-63(x26) allele, with its αC151Y mutation disrupting the Cys-loop, have deficient muscle function reflected by impaired swimming (thrashing). Single-channel recordings from cultured muscle cells from the mutant strain showed a 100-fold reduced frequency of opening events and shorter channel openings of L-nAChRs compared with those of wild-type worms. Anti-UNC-63 antibody staining in both cultured adult muscle and embryonic cells showed that L-nAChRs were expressed at similar levels in the mutant and wild-type cells, suggesting that the functional changes in the receptor, rather than changes in expression, are the predominant effect of the mutation. The kinetic changes mimic those reported in patients with fast-channel congenital myasthenic syndromes. We show that pyridostigmine bromide and 3,4-diaminopyridine, which are drugs used to treat fast-channel congenital myasthenic syndromes, partially rescued the motility defect seen in unc-63(x26). The C. elegans unc-63(x26) mutant may therefore offer a useful model to assist in the development of therapies for syndromes produced by altered function of human nAChRs.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/metabolism , Muscles/metabolism , Neuromuscular Junction/metabolism , Receptors, Nicotinic/metabolism , 4-Aminopyridine/analogs & derivatives , 4-Aminopyridine/pharmacology , Amifampridine , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/genetics , Cholinesterase Inhibitors/pharmacology , Disease Models, Animal , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Humans , Mutation , Myasthenic Syndromes, Congenital/drug therapy , Myasthenic Syndromes, Congenital/genetics , Myasthenic Syndromes, Congenital/metabolism , Potassium Channel Blockers/pharmacology , Protein Structure, Secondary , Pyridostigmine Bromide/pharmacology , Receptors, Nicotinic/genetics , Swimming
14.
EMBO J ; 28(17): 2636-49, 2009 Sep 02.
Article in English | MEDLINE | ID: mdl-19609303

ABSTRACT

Nicotinic acetylcholine receptors (nAChRs) are homo- or heteropentameric ligand-gated ion channels mediating excitatory neurotransmission and muscle activation. Regulation of nAChR subunit assembly and transfer of correctly assembled pentamers to the cell surface is only partially understood. Here, we characterize an ER transmembrane (TM) protein complex that influences nAChR cell-surface expression and functional properties in Caenorhabditis elegans muscle. Loss of either type I TM protein, NRA-2 or NRA-4 (nicotinic receptor associated), affects two different types of muscle nAChRs and causes in vivo resistance to cholinergic agonists. Sensitivity to subtype-specific agonists of these nAChRs is altered differently, as demonstrated by whole-cell voltage-clamp of dissected adult muscle, when applying exogenous agonists or after photo-evoked, channelrhodopsin-2 (ChR2) mediated acetylcholine (ACh) release, as well as in single-channel recordings in cultured embryonic muscle. These data suggest that nAChRs desensitize faster in nra-2 mutants. Cell-surface expression of different subunits of the 'levamisole-sensitive' nAChR (L-AChR) is differentially affected in the absence of NRA-2 or NRA-4, suggesting that they control nAChR subunit composition or allow only certain receptor assemblies to leave the ER.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Endoplasmic Reticulum/metabolism , Membrane Proteins/metabolism , Protein Subunits/metabolism , Receptors, Nicotinic/metabolism , Synapses/metabolism , Action Potentials , Animals , Animals, Genetically Modified , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/genetics , Electrophysiology , Humans , Receptors, Nicotinic/genetics
15.
J Neurosci ; 29(18): 6022-32, 2009 May 06.
Article in English | MEDLINE | ID: mdl-19420269

ABSTRACT

Homo-pentameric Cys-loop receptors contain five identical agonist binding sites, each formed at a subunit interface. To determine the number and locations of binding sites required to generate a stable active state, we constructed a receptor subunit with a mutation that disables the agonist binding site and a reporter mutation that alters unitary conductance and coexpressed mutant and nonmutant subunits. Although receptors with a range of different subunit compositions are produced, patch-clamp recordings reveal that the amplitude of each single-channel opening event reports the number and, for certain subunit combinations, the locations of subunits with intact binding sites. We find that receptors with three binding sites at nonconsecutive subunit interfaces exhibit maximal mean channel open time, receptors with binding sites at three consecutive or two nonconsecutive interfaces exhibit intermediate open time, and receptors with binding sites at two consecutive or one interface exhibit brief open time. Macroscopic recordings after rapid application of agonist reveal that channel activation slows and the extent of desensitization decreases as the number of binding sites per receptor decreases. The overall results provide a framework for defining mechanisms of activation and drug modulation for homo-pentameric Cys-loop receptors.


Subject(s)
Binding Sites , Cysteine/metabolism , Nicotinic Agonists/metabolism , Receptors, Nicotinic/chemistry , Acetylcholine/pharmacology , Allosteric Regulation/drug effects , Allosteric Regulation/genetics , Amino Acids/genetics , Binding Sites/drug effects , Binding Sites/genetics , Binding, Competitive/drug effects , Binding, Competitive/genetics , Biophysical Phenomena/drug effects , Biophysical Phenomena/genetics , Bungarotoxins/metabolism , Cell Line, Transformed , Cysteine/genetics , Dose-Response Relationship, Drug , Electric Stimulation/methods , Gene Expression/physiology , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/genetics , Membrane Potentials/drug effects , Membrane Potentials/genetics , Models, Molecular , Mutagenesis, Site-Directed/methods , Patch-Clamp Techniques , Protein Conformation , Receptors, Nicotinic/genetics , Receptors, Nicotinic/metabolism , Receptors, Serotonin, 5-HT3/genetics , Receptors, Serotonin, 5-HT3/metabolism , Structure-Activity Relationship , Transfection/methods , alpha7 Nicotinic Acetylcholine Receptor
16.
Mol Pharmacol ; 71(5): 1407-15, 2007 May.
Article in English | MEDLINE | ID: mdl-17314321

ABSTRACT

Nicotinic acetylcholine receptors (nAChRs) are pentameric neurotransmitter-gated ion channels that mediate synaptic transmission throughout the nervous system in vertebrates and invertebrates. Caenorhabditis elegans is a nonmammalian model for the study of the nervous system and a model of parasitic nematodes. Nematode muscle nAChRs are of considerable interest because they are targets for anthelmintic drugs. We show single-channel activity of C. elegans muscle nAChRs for the first time. Our results reveal that in the L1 larval stage acetylcholine (ACh) activates mainly a levamisole-sensitive nAChR (L-AChR). A single population of 39 pS channels, which are 5-fold more sensitive to levamisole than ACh, is detected. In contrast to mammalian nAChRs, open durations are longer for levamisole than for ACh. Studies in mutant strains reveal that UNC-38, UNC-63, and UNC-29 subunits are assembled into a single L-AChR in the L1 stage and that these subunits are irreplaceable, suggesting that they are vital for receptor function throughout development. Recordings from a strain mutated in the LEV-1 subunit show a main population of channels with lower conductance (26 pS), prolonged open durations, and reduced sensitivity to levamisole. Thus, although LEV-1 is preferentially incorporated into native L-AChRs, receptors lacking this subunit can still function. No single-channel activity from levamisole-insensitive nAChRs is detected. Thus, during neuromuscular transmission in C. elegans, the majority of ACh-activated current flows through L-AChRs. This study contributes to the understanding of the molecular mechanisms underlying functional diversity of the nAChR family and offers an excellent strategy to test novel antiparasitic drugs.


Subject(s)
Caenorhabditis elegans/metabolism , Ion Channel Gating , Muscles/metabolism , Receptors, Nicotinic/metabolism , Acetylcholine/pharmacology , Animals , Caenorhabditis elegans/drug effects , Caenorhabditis elegans Proteins/genetics , Ion Channel Gating/drug effects , Levamisole/pharmacology , Morantel/pharmacology , Muscles/drug effects , Mutant Proteins/metabolism , Pyrantel/pharmacology
17.
Mol Pharmacol ; 70(4): 1307-18, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16825485

ABSTRACT

Nicotinic receptors (acetylcholine receptors, AChRs) play key roles in synaptic transmission throughout the nervous system. AChRs mediate neuromuscular transmission in nematodes, and they are targets for antiparasitic drugs. The anthelmintic agents levamisole and pyrantel, which are potent agonists of nematode muscle AChRs, are partial agonists of mammalian muscle AChRs. To further explore the structural basis of the differential activation of AChR subtypes by anthelmintics, we studied the activation of alpha7 AChRs using the high-conductance form of the alpha7-5-hydroxytryptamine-3A receptor, which is a good model for pharmacological studies involving the extracellular region of alpha7. Macroscopic and single-channel current recordings show that levamisole is a weak agonist of alpha7. It is interesting that pyrantel is a more potent agonist of alpha7 than acetylcholine (ACh). To identify determinants of this differential activation, we replaced residues of the complementary face of the binding site by the homologous residues in the muscle epsilon subunit and evaluated changes in activation. The mutation Q57G does not affect the activation by either ACh or levamisole. However, it increases EC50 values and decreases the maximal response to pyrantel. Kinetic analysis shows that gating of the mutant channel activated by pyrantel is profoundly impaired. The decreased sensitivity of alpha7-Q57G to pyrantel agrees with its weak action at muscle AChRs, indicating that when glycine occupies position 57, as in the mammalian muscle AChR, pyrantel behaves as a partial agonist. Thus, position 57 located at the complementary face of the binding site plays a key role in the selective activation of AChRs by pyrantel.


Subject(s)
Levamisole/pharmacology , Nicotinic Agonists/pharmacology , Pyrantel/pharmacology , Receptors, Nicotinic/chemistry , Receptors, Serotonin/metabolism , Acetylcholine/pharmacology , Amino Acid Sequence , Animals , Anthelmintics/pharmacology , Binding Sites , Humans , Membrane Potentials , Models, Biological , Molecular Sequence Data , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT3 , Sequence Homology, Amino Acid
18.
Mol Pharmacol ; 68(5): 1475-83, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16118362

ABSTRACT

The receptor chimera alpha7-5HT3A has served as a prototype for understanding the pharmacology of alpha7 neuronal nicotinic receptors, yet its low single channel conductance has prevented studies of the activation kinetics of single receptor channels. In this study, we show that introducing mutations in the M3-M4 cytoplasmic linker of the chimera alters neither the apparent affinity for the agonist nor the EC50 but increases the amplitude of agonist-evoked single channel currents to enable kinetic analysis. Channel events appear as single brief openings flanked by long closings or as bursts of several openings in quick succession. Both the open and closed time distributions are described as the sum of multiple exponential components, but these do not change over a wide range of acetylcholine (ACh), nicotine, or choline concentrations. Bursts elicited by a saturating concentration of ACh contain brief and long openings and closings, and a cyclic scheme containing two open and two closed states is found to adequately describe the data. The analysis indicates that once fully occupied, the receptor opens rapidly and efficiently, and closes and reopens several times before it desensitizes. Channel closing and desensitization occur at similar rates and account for the invariant open and closed time distributions.


Subject(s)
Ion Channels/physiology , Receptors, Nicotinic/physiology , Receptors, Serotonin, 5-HT3/physiology , Acetylcholine/pharmacology , Animals , Cell Line , Choline/pharmacology , Electric Conductivity , Kinetics , Mice , Nicotine/pharmacology , Recombinant Fusion Proteins/physiology , alpha7 Nicotinic Acetylcholine Receptor
19.
J Neuroimmunol ; 160(1-2): 154-61, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15710468

ABSTRACT

The presence of nicotinic receptors (nAChRs) in blood cells has been demonstrated. However, little is known about their functional roles. We have detected mRNA of alpha7 nAChR in peripheral human lymphocytes and determined that its expression is highly variable among individuals and within the same individual at different times. Upregulation of alpha7 is systematically observed after incubation of lymphocytes with nicotine or alpha-bungarotoxin. In addition, the incubation with these drugs decreases the percentage of apoptotic cells induced by the exposure to cortisol. Our results suggest that alpha7 nAChRs are involved in the modulation of cortisol-induced apoptosis.


Subject(s)
Apoptosis/immunology , Lymphocytes/cytology , Lymphocytes/metabolism , Receptors, Nicotinic/physiology , Adult , Animals , Apoptosis/drug effects , Bungarotoxins/pharmacology , Cells, Cultured , Humans , Hydrocortisone/pharmacology , Lymphocytes/drug effects , Muscle, Skeletal/metabolism , Nicotine/pharmacology , Nicotinic Antagonists/pharmacology , Oxidation-Reduction , Protein Subunits/biosynthesis , Protein Subunits/genetics , RNA, Messenger/analysis , Rats , Rats, Wistar , Receptors, Nicotinic/biosynthesis , Receptors, Nicotinic/genetics , Tetrazolium Salts/metabolism , Thiazoles/metabolism , Up-Regulation/drug effects , alpha7 Nicotinic Acetylcholine Receptor
20.
Nature ; 430(7002): 896-900, 2004 Aug 19.
Article in English | MEDLINE | ID: mdl-15318223

ABSTRACT

Neurotransmitter receptors from the Cys-loop superfamily couple the binding of agonist to the opening of an intrinsic ion pore in the final step in rapid synaptic transmission. Although atomic resolution structural data have recently emerged for individual binding and pore domains, how they are linked into a functional unit remains unknown. Here we identify structural requirements for functionally coupling the two domains by combining acetylcholine (ACh)-binding protein, whose structure was determined at atomic resolution, with the pore domain from the serotonin type-3A (5-HT3A) receptor. Only when amino-acid sequences of three loops in ACh-binding protein are changed to their 5-HT3A counterparts does ACh bind with low affinity characteristic of activatable receptors, and trigger opening of the ion pore. Thus functional coupling requires structural compatibility at the interface of the binding and pore domains. Structural modelling reveals a network of interacting loops between binding and pore domains that mediates this allosteric coupling process.


Subject(s)
Acetylcholine/metabolism , Carrier Proteins/agonists , Carrier Proteins/metabolism , Ion Channel Gating/drug effects , Ion Channels/agonists , Ion Channels/metabolism , Allosteric Regulation , Amino Acid Sequence , Animals , Carrier Proteins/chemistry , Carrier Proteins/genetics , Cell Line , Electric Conductivity , Ion Channels/chemistry , Ion Channels/genetics , Membrane Potentials , Models, Molecular , Protein Binding , Protein Structure, Tertiary , Rats , Receptors, Serotonin, 5-HT3/chemistry , Receptors, Serotonin, 5-HT3/genetics , Receptors, Serotonin, 5-HT3/metabolism , Recombinant Fusion Proteins/agonists , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Serotonin 5-HT3 Receptor Agonists
SELECTION OF CITATIONS
SEARCH DETAIL